Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Stem Cell Res. 2023 May 17;69:103125. doi: 10.1016/j.scr.2023.103125

Resource Table:

Unique stem cell lines identifier NIAi002-A
NIAi002-A-1
NIAi002-A-2
NIAi002-A-3
NIAi003-A
NIAi003-A-1
NIAi003-A-2
NIAi003-A-3

Alternative names of stem cell lines A53T SNCA 40760 (NIAi002-A)
Iso-WT SNCA 40760 PL1E11 (NIAi002-A-1)
Iso-WT SNCA 40760 PL3B3 (NIAi002-A-2)
Iso-WT SNCA 40760 PL3B7 (NIAi002-A-3)
A53T SNCA 42720 (NIAi003-A)
Iso-WT SNCA 42720 PL2B9 (NIAi003-A-1)
Iso-WT SNCA 42072 PL2C11 (NIAi003-A-2)
Iso-WT SNCA 42072 PL3G1 (NIAi003-A-3)

Institution National Institutes of Health, National Institute on Aging

Contact information of distributor Mark R Cookson: cookson@mail.nih.gov

Type of cell lines iPSC

Origin Human
Cell Source The Michael J. Fox Foundation for Parkinson’s Research (MJFF), Parkinson’s Progression Markers Initiative (PPMI).

Clonality Clonal

Method of reprogramming Sendai virus

Multiline rationale Isogenic clones from two unrelated donors carrying the same pathogenic variant in a PD related gene

Gene modification Yes

Type of modification Revert SNCA p.A53T to WT sequence

Associated disease Parkinson’s disease

Gene/locus SNCA/PARK1

Method of modification RNP CRISPR/Cas9

Name of transgene or resistance N/A

Inducible/constitutive system N/A

Date archived/stock date N/A

Cell line repository/bank Indiana University
https://hpscreg.eu/cell-line/NIAi002-A
https://hpscreg.eu/cell-line/NIAi002-A-1
https://hpscreg.eu/cell-line/NIAi002-A-2
https://hpscreg.eu/cell-line/NIAi002-A-3
https://hpscreg.eu/cell-line/NIAi003-A
https://hpscreg.eu/cell-line/NIAi003-A-1
https://hpscreg.eu/cell-line/NIAi003-A-2
https://hpscreg.eu/cell-line/NIAi003-A-3

Ethical approval Original line obtained from MJFF. Ethical licence/Sponsor Protocol number: 001.